logo

Tricida, Inc. (TCDA)



Trade TCDA now with
  Date
  Headline
6/25/2019 8:36:43 AM Tricida Announces Publication Of Positive Long-Term Phase 3 Clinical Trial Results Of Veverimer In The Lancet
4/3/2019 10:31:32 PM Tricida Prices Public Offering Of 5.60 Mln Shares At $36.00/shr
3/28/2019 7:29:18 AM Tricida Announces Positive Results From Long-Term Trial Of TRC101 In Patients With CKD And Metabolic Acidosis
3/28/2019 7:15:28 AM Tricida Q4 Loss/shr $0.66 Vs. Loss/shr $9.05 Prior Year
3/11/2019 8:35:53 AM Tricida Announces Publication Of Positive TRC101 Pivotal Trial Results In The Lancet